New Report: TELUS Health's inaugural Pharmacy Trends market analysis unveils Canadian pharmacies poised for $1.9B tech-driven transformation Français
Advanced pharmacy systems enabling seamless collaboration and digital technology putting prescription management at patients' fingertips
TORONTO, May 20, 2025 /CNW/ - Canada's pharmacy sector is undergoing a revolution to meet changing healthcare needs, according to TELUS Health's inaugural Pharmacy Trends Report: The Future of Pharmacy in Canada: Five Trends Shaping Canada's Healthcare Landscape in 2025. With the automated central fill pharmacy market projected to reach $1.9 billion by 2030 and Canada's specialty pharmacy market expected to exceed $20 billion, technological automation is enabling pharmacists to step into expanded healthcare roles, fundamentally changing how people in Canada access primary care services.
View PDF
"We're witnessing a seismic shift in Canadian healthcare delivery," said Ratcho Batchvarov, Vice-president, Provider Solutions, TELUS Health. "Our first Pharmacy Trends report reveals that pharmacies are rapidly evolving into comprehensive healthcare hubs, bridging critical gaps in primary care access. With the specialty pharmacy market set to surge beyond $20 billion and automation driving a $1.9 billion revolution in central fill services, we're not just talking about incremental change – this is a fundamental reimagining of community healthcare. Pharmacists have been advancing their role as frontline care providers, leveraging cutting-edge technology to offer more accessible, efficient and personalized care. This transformation is creating a more resilient and responsive healthcare ecosystem for all Canadians."
The Pharmacy Trends Report provides valuable insights on how the Canadian pharmacy sector is evolving, enabling both pharmacists and pharmacy managers to identify opportunities for improved efficiencies in their practice and enhance patient care. Three notable trends from this first report include:
Putting an expanded scope of practice into action: As millions of people in Canada struggle to find a family doctor, the nation's network of more than 10,000 licensed pharmacies is stepping up to fill critical healthcare gaps. These locations offer essential medical services, from vaccinations to prescribing medications for minor ailments.
Patients see their pharmacists 1.5 to 10 times more than they see their primary care physician.
Enhancing collaboration and streamlining operations: technology solutions can empower pharmacists to deliver their services in a way that's comfortable to them, and patients can access consistent services and care, regardless of where they go:
Centralized prescription fulfillment reduces errors and administrative burdens, allowing pharmacists to focus on patient care. Over a quarter of community pharmacists in one survey noted their dissatisfaction with the daily volume of prescriptions to be processed.
Advanced Pharmacy Management Systems allow pharmacists to collaborate seamlessly with other healthcare providers, ensuring patients receive consistent, well-coordinated care across all touchpoints.
Specialty drug claims have tripled over the past 15 years, rising from 10.4 per cent to 32.8 per cent of total pharmacy claims. This dramatic increase means pharmacists must now manage more complex medication regimens while ensuring patients receive proper guidance and care.
Engaging the patient: patients are taking control of their healthcare through digital technology. Modern pharmacy apps put prescription management at their fingertips, while allowing them to securely track their health data. This digital connection helps pharmacists spot health trends earlier and deliver more personalized care when patients need it most.
" A recent survey found that 82 per cent of people in Canada reported being interested in virtual care appointments, showing yet again how patients are looking for more control of their healthcare journey," explained Batchvarov. "Embracing this type of patient engagement, while providing a platform that keeps personal medical information confidential with the highest data security protocols, is a key way forward in securing the trust of patients."
The newly released 2025 Pharmacy Trends Report sparked valuable discussion at the company's recent Annual Conference in Toronto on April 29, 2025 — a key forum that brought together leaders from the healthcare, pharmacy, insurance and benefits sectors. This year's conference explored a comprehensive approach to connected healthcare, encompassing the pharmacy, physician and public health sectors, while reaffirming our dedication to data-informed and technology-driven solutions for Canada's healthcare ecosystem.
About TELUS Health
TELUS Health is on a mission to become the most trusted wellbeing company in the world by enhancing the overall efficiency of healthcare and championing workplace wellbeing. By integrating advanced healthcare technology with comprehensive employee support services, TELUS Health provides a holistic approach to primary and preventive health and wellbeing enhancing more than 150 million lives across more than 200 countries and territories. Our innovative digital health platforms, including electronic medical records (EMRs) and virtual care solutions, empower healthcare professionals, employers and governments to deliver personalized care efficiently. Our employee wellbeing programs empower individuals by offering extensive support through Employee and Family Assistance Programs (EFAPs), mental health resources, financial counselling and workplace wellness initiatives. At TELUS Health, we are committed to revolutionizing healthcare to ensure people receive the support they need and employees thrive both personally and professionally. Together, let's make the future friendly. For more information please visit: www.telushealth.com.
For media inquiries, please contact:
Marielle Hossack
TELUS Health
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
2 minutes ago
- National Post
Gold Reserve Provides Update on Objections to the Special Master's Final Recommendation in the CITGO Sale Process
Article content PEMBROKE, Bermuda — Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) ('Gold Reserve' or the 'Company') announces that, pursuant to the schedule set by the U.S. District Court for the District of Delaware (the 'Court'), various parties filed memoranda in support of objections to the Special Master's Final Recommendation that Gold Reserve's U.S. acquisition subsidiary, Dalinar Energy Corporation, should be selected by the Court to purchase the shares of PDV Holding, Inc. ('PDVH'), the indirect parent company of CITGO Petroleum Corp. ('CITGO'). Article content The objections mostly tracked the 'Notices of Objection' filed on July 7, 2025 (and announced by the Company here) but, in a material change, Red Tree Investments LLC ('Red Tree') stated that 'it no longer objects on the basis that the Court should pick its bid instead of Gold Reserve's.' This means that the Gold Reserve / Dalinar Energy bid recommended by the Special Master is the only conforming bid remaining in the Delaware Sale Process. Article content The parties that filed memoranda in support of objections are as follows: Article content Red Tree; Crystallex International Corporation; the ConocoPhillips companies (filed a 'limited objection'); the ACL1 companies and OI European Group B.V. (both filed short joinders to certain of the objections filed by Crystallex and the ConocoPhillips companies); the 'Venezuela Parties' (the Bolivarian Republic of Venezuela, PDVSA, PDVH and CITGO) (filed under seal); and the 2020 bondholders (joined by the Trustee and Collateral Agent for the 2020 bonds). Article content Under the Court's schedule, responses to the objections are due by August 7, 2025, and further briefing is then to take place in advance of the August 18, 2025 Sale Hearing. A period of limited discovery regarding the objections is now ongoing. Article content A copy of the filings can be found here. Article content A complete description of the Delaware sale proceedings can be found on the Public Access to Court Electronic Records system in Crystallex International Corporation v. Bolivarian Republic of Venezuela, 1:17-mc-00151-LPS (D. Del.) and its related proceedings. Article content Cautionary Statement Regarding Forward-Looking statements Article content This release contains 'forward-looking statements' within the meaning of applicable U.S. federal securities laws and 'forward-looking information' within the meaning of applicable Canadian provincial and territorial securities laws and state Gold Reserve's and its management's intentions, hopes, beliefs, expectations or predictions for the future. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. They are frequently characterized by words such as 'anticipates', 'plan', 'continue', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate', 'may', 'will', 'potential', 'proposed', 'positioned' and other similar words, or statements that certain events or conditions 'may' or 'will' occur. Forward-looking statements contained in this press release include, but are not limited to, statements relating to any bid submitted by the Company for the purchase of the PDVH shares (the 'Bid'). Article content We caution that such forward-looking statements involve known and unknown risks, uncertainties and other risks that may cause the actual events, outcomes or results of Gold Reserve to be materially different from our estimated outcomes, results, performance, or achievements expressed or implied by those forward-looking statements, including but not limited to: the discretion of the Special Master to consider the Bid, to enter into any discussions or negotiation with respect thereto; the Bid will not be approved by the Court as the 'Final Recommend Bid' under the Bidding Procedures, and if approved by the Court may not close, including as a result of not obtaining necessary regulatory approvals, including but not limited to any necessary approvals from the U.S. Office of Foreign Asset Control ('OFAC'), the U.S. Committee on Foreign Investment in the United States, the U.S. Federal Trade Commission or the TSX Venture Exchange; failure of the Company or any other party to obtain sufficient equity and/or debt financing or any required shareholders approvals for, or satisfy other conditions to effect, any transaction resulting from the Bid; that the Company may forfeit any cash amount deposit made due to failing to complete the Bid or otherwise; that the making of the Bid or any transaction resulting therefrom may involve unexpected costs, liabilities or delays; that, prior to or as a result of the completion of any transaction contemplated by the Bid, the business of the Company may experience significant disruptions due to transaction related uncertainty, industry conditions, tariff wars or other factors; the ability to enforce the writ of attachment granted to the Company; the timing set for various reports and/or other matters with respect to the Sale Process may not be met; the ability of the Company to otherwise participate in the Sale Process (and related costs associated therewith Article content ) Article content ; the amount, if any, of proceeds associated with the Sale Process; the competing claims of other creditors of Venezuela, PDVSA and the Company, including any interest on such creditors' judgements and any priority afforded thereto; uncertainties with respect to possible settlements between Venezuela and other creditors and the impact of any such settlements on the amount of funds that may be available under the Sale Process; and the proceeds from the Sale Process may not be sufficient to satisfy the amounts outstanding under the Company's September 2014 arbitral award and/or corresponding November 15, 2015 U.S. judgement in full; and the ramifications of bankruptcy with respect to the Sale Process and/or the Company's claims, including as a result of the priority of other claims. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements. For a more detailed discussion of the risk factors affecting the Company's business, see the Company's Management's Discussion & Analysis for the year ended December 31, 2024 and other reports that have been filed on SEDAR+ and are available under the Company's profile at Article content Investors are cautioned not to put undue reliance on forward-looking statements. All subsequent written and oral forward-looking statements attributable to Gold Reserve or persons acting on its behalf are expressly qualified in their entirety by this notice. Gold Reserve disclaims any intent or obligation to update publicly or otherwise revise any forward-looking statements or the foregoing list of assumptions or factors, whether as a result of new information, future events or otherwise, subject to its disclosure obligations under applicable rules promulgated by applicable Canadian provincial and territorial securities laws. Article content Article content Article content Article content
Cision Canada
2 minutes ago
- Cision Canada
From Survival to Self-Mastery in 90 Days: New Program Helps Women Stop Self-Abandoning and Rise into High-Value Leadership
Elaine Yuen Healer Inc. introduces a 13-week coaching program that helps high-achieving women over 30 build confidence, master emotional intelligence, and reconnect with their intuition to bridge the leadership gap TORONTO, July 25, 2025 /CNW/ -- In a world where performance doesn't always guarantee promotion, Elaine Yuen Healer Inc. launches ThriveConfidence Self-Mastery ™, a transformational and structured 13-week coaching program designed for high-achieving women over 30 who feel overlooked, undervalued, or stuck in survival mode. By blending emotional mastery, intuitive empowerment, and holistic alignment, the program helps women overcome the emotional and energetic barriers that have long held them back from stepping into confident and high-value leadership. Despite making up 41.2% of the global workforce, women hold only 28.8% of senior leadership roles—a number that has seen little change since 2022 (Global Gender Gap Report 2025). ThriveConfidence Self-Mastery™ addresses this imbalance by going beyond surface-level strategies to build deep internal resilience, confidence, and clarity. "Many brilliant women still feel unseen—trapped in burnout, imposter syndrome, and cycles of self-doubt," says Elaine Yuen, founder of Elaine Yuen Healer Inc."This program was designed to shift them from invisible to influential, through emotional mastery and self-trust." Relevant data further reinforces the need for this approach: Women are 14% less likely to be promoted despite stronger performance (Forbes). 34% of unappreciated women at work report mental health struggles (Digital Business). The ongoing 'double burden' of caregiving and career impedes advancement (Morson Talent). The program is structured around four transformational pillars: Elevate Confidence Master Emotional Intelligence Awaken Intuition & Creativity Align Body, Mind & Soul Each week includes intuitive coaching, spiritual tools, guided meditations, and self-reflection practices, helping participants shift from surviving to thriving—without burnout. "It's for the underdog woman who knows she's capable of more but keeps getting passed over," Yuen adds. "It's time she stops waiting for permission and leads from within—with unshakable confidence." ThriveConfidence Self-Mastery™ is now open for enrollment. To book a free strategy session, visit or browse offerings at Elaine Yuen Healer Inc. helps high-achieving women break generational patterns, reclaim self-worth, and lead with authenticity. Through intuitive guidance and immersive coaching, clients are supported in building emotional resilience and sustainable leadership.
Cision Canada
2 minutes ago
- Cision Canada
Canada Life Investment Management Ltd. announces changes to mutual funds Français
LONDON, ON, July 25, 2025 /CNW/ - Canada Life Investment Management Ltd. (CLIML) today announced changes including the change in risk rating and investment strategy for select funds and the management fee reduction of Counsel Money Market, effective July 25, 2025. Risk Rating Changes CLIML reviews and adjusts its funds' risk ratings in accordance with the Risk Classification Methodology mandated by Canadian securities regulators. The risk rating of the following mutual funds will change as outlined below and are the result of the most recent annual review. Investment Strategy Changes To provide the opportunity for additional geographical diversification, the investment strategies for Counsel Canadian Value will change to reflect a greater foreign investments allowance, up to 49% from 30%. Management Fee Changes To deliver improved pricing to investors, CLIML is reducing the management fee of Counsel Money Market as follows: In addition to the changes noted above, CLIML today announced changes to allow investors to purchase Canada Life Mutual Funds if their dealers have signed an agreement with CLIML permitting the purchase of the Canada Life Mutual Funds. About Canada Life Investment Management Ltd. Canada Life Investment Management Ltd. is an investment management firm offering wealth management products and services for individuals, families and business owners. The funds are sub-advised by leading asset managers, providing access to specialized investment expertise from around the world. CLIML is a subsidiary of The Canada Life Assurance Company. Learn more. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.
